# Rethinking Neonatal Vaccination Policies: A Neuroimmune Perspective

## TL;DR

This paper reviews how early-life vaccinations might affect brain and immune development, suggesting a cautious approach to neonatal vaccine timing.

## Contribution

The paper introduces the ALLARA principle for individualized neonatal vaccination strategies based on neuroimmune interactions.

## Key findings

- Vaccine-induced immune activation may influence brain development via epigenetic and cytokine pathways.
- Immune overstimulation and microbiome disruption could be linked to autoimmune and neurodevelopmental risks.
- Current evidence gaps highlight the need for more research on long-term neurological and immunological outcomes.

## Abstract

Neonatal vaccination is a cornerstone of early-life infectious disease prevention. However, the timing and safety of these interventions require careful consideration. This review explored the neuroimmune implications of early immunization, with a specific focus on the interplay between the developing immune and nervous systems. We examined potential mechanisms through which vaccine-induced immune activation might influence brain development, through epigenetic modifications and sustained cytokine responses, particularly involving interleukin-6 (IL-6). The discussion addressed concerns related to immune overstimulation, regulatory T-cell suppression, and microbiome disruption, considering their potential links to autoimmune and neurodevelopmental disorders. In light of the identified evidence gaps, we advocate for a cautious, individualized vaccination approach guided by the “As Low and Late As Reasonably Achievable” (ALLARA) principle. This strategy aimed to balance robust protection against infectious diseases with the imperative of safeguarding lifelong neurological and immunological health.